MoA Video Series

Emerging Treatment Mechanisms in Hemophilia:
Overview

Emerging Treatment Mechanisms in Hemophilia:
Efanesoctocog Alfa

Emerging Treatment Mechanisms in Hemophilia:
Emicizumab and Mim8

Emerging Treatment Mechanisms in Hemophilia:
Fitusiran

Infographics

Redefining
Strategies for
the Management
of Hemophilia:
Examining the
Clinical Potential of
Rebalancing Therapies

Achieving Freedom
From Bleeding:
Exploring the Evolving
Evidence on New and Emerging
Treatment Strategies to
Maintain Higher FVIII Levels

Redefining
Strategies for
the Management
of Hemophilia:
Practical Assessment of
Joint Health and Predicting/Mitigating Progression

Hemostasis in Hemophilia - Mechanisms of Disease and Rationale for New Therapies

Attaining New Goals in Hemophilia - Exploring the Clinical Utility of Emerging Treatments

Advancing Treatment for Memophilia B - Exploring Extravascular Hemostasis and Optimizing Factor Replacement Monitoring and Implementation

Rebalancing the Coagulation Cascade - Emerging Strategies To Restore Hemostasis In Hemophilia

Frequently Asked Questions

Suggested Readings

Hemophilia A and B: Presentation Transcripts and Translations

Improving Quality of Life for People Living With Hemophilia: Strategies to Stratify Joint Damage Risk and Allow Increased Participation in Physical Activity

Translations

Tipping the Scale Back Towards Normal: Evaluating Rebalancing Therapies to Achieve
Hemostasis in Hemophilia

Translations

Achieving Freedom From Bleeding: Exploring the Evolving Evidence on New and Emerging
Treatment Strategies to Maintain Higher FVIII Levels

Translations

Achieving and Sustaining Higher FVIII Levels in Hemophilia A: Exploring Real-world
Strategies for Treatment and Monitoring Trough Levels Considering New Treatment Options

Translations

Optimizing Management in Hemophilia B: Exploring the Impact of Extravascular Distribution on
Hemostasis

Translations

Hemostasis in Hemophilia: How Improved Disease Knowledge Informs New Treatments

Translations

Hemophilia A and B: Guidelines List

American Society of Hematology/International Society on Thrombosis and Hemostasis (ASH/ISTH; endorsed)

NHF-McMaster Guideline on Care Models for Haemophilia Management

Special Issue: National Haemophilia Foundation-McMaster University Guideline on Care Models for Haemophilia Management. Guest Editor: Christine Lee. This work was funded by the National Hemophilia Foundation. Panel members were not compensated for their participation

International consensus recommendations on the management of people with haemophilia B (at PubMed)

International consensus recommendations on the management of people with haemophilia B (at SAGE journals)

The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH

International Society on Thrombosis and Hemostasis (ISTH)

The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH

National Hemophilia Foundation (NHF) Medical and Scientific Advisory Council (MASAC)

Prophylaxis for Hemophilia A and B with and without Inhibitors

Standards and Criteria for the Care of Persons with Congenital Bleeding Disorders

Recommendations on Standardized Testing and Surveillance for Inhibitors in Patients with Hemophilia A and B

World Federation of Hemophilia (WFH)

WFH Guidelines for the Management of Hemophilia, 3rd edition

World Federation of Hemophilia eLearning Site